Dr. Peter Asaga Mac is a dedicated researcher at Universitätsklinikum Freiburg, Freiburg im Breisgau, Germany, specializing in infectious and zoonotic diseases. His scientific work focuses on understanding the epidemiology, immune response, and transmission dynamics of emerging viral infections, particularly mosquito-borne diseases such as Chikungunya and Dengue. Through a combination of field-based studies, serological analyses, and molecular surveillance, Dr. Mac investigates how co-circulating arboviruses interact within populations and contribute to public health challenges in endemic regions, especially in Africa. His notable publication, “An Undetected Expansion, Spread, and Burden of Chikungunya and Dengue Cocirculating Antibodies in Nigeria” (Zoonotic Diseases, 2024), provides valuable insight into the unnoticed expansion of these viruses and their long-term implications for disease control strategies. Dr. Mac’s research is characterized by its translational value—bridging scientific discovery with actionable health interventions to improve epidemic preparedness and response. His collaborations with international scientists strengthen global efforts to monitor zoonotic threats and develop more resilient surveillance systems. Despite being an early-career researcher, his contributions are gaining recognition within the academic community. With 3 publications, 14 citations and an h-index of 2, Dr. Mac’s growing academic footprint reflects his potential to make lasting contributions to infectious disease research, particularly in the areas of viral immunology, epidemiological modeling, and global health resilience. His commitment to evidence-based solutions continues to shape a better understanding of emerging diseases and their impact on human health worldwide.
Profiles: Scopus | ORCID | Google Scholar
Featured Publications
1. Chackalackal, D. J., Al-Aghbari, A. A. A., Jang, S. Y., Ramirez, T. R., Vincent, J., Joshi, A., et al. (2021). The Covid-19 pandemic in low- and middle-income countries: Who carries the burden? Review of mass media and publications from six countries. Pathogens and Global Health, 115(3), 178–187.
Cited by: 49
2. Mac, P. A., Suleiman, A. C., & Airiohuodion, P. E. (2019). High prevalence of hepatitis B virus infection among pregnant women attending antenatal care in Central Nigeria. Journal of Infectious Diseases and Epidemiology, 5(1), 068.
Cited by: 34
3. Mac, P. A., Asheadzi, H. F., Gideon, A., Thaker, P., & Airiohuodion, P. (2019). Prevalence of Plasmodium falciparum among Nigerians in Abuja and Central States: A comparative analysis of sensitivity and specificity using rapid diagnostic test and microscopy. International Journal of Tropical Diseases, 1, 014.
Cited by: 22
4. Mac, P. A., Kroeger, A., & Airiohuodion, P. E. (2019). Needs assessment of emergency medical and rescue services in Abuja/Nigeria and environs. BMC Emergency Medicine, 19(78), 8.
Cited by: 21
5. Mac, P. A., Airiohuodion, P. E., Yako, A. B., et al. (2022). The seroprevalence and hidden burden of chikungunya endemicity and malaria mono- and coinfection in Nigeria. International Journal of Environmental Research and Public Health, 19(15), 8896.
Cited by: 19